Jennifer Ringler

Jim Currie and Baber Ghauri talk to Pharm Exec about making connections that resonate with audiences in a digital world.

Over 25 years the Rx Club Show has reflected dramatic technological changes in advertising. But, as always, the subject comes first, the medium second. So where did the accolades go this year?

The rise of advocacy groups has helped patients find their voice, but the power to change health profiles remains an elusive goal.

Abbey Meyers, Founder, National Organization of Rare Disorders

A Q&A with Andrew Webber, President and CEO of the National Business Coalition on Health

Cloud computing is slowly but surely becoming the IT platform of choice for the industry. Pharm Exec looks at how it now affects nearly every aspect of the pharma business.

Novartis' Gilenya is a step forward in treating Multiple Sclerosis. But generating increased compliance is another story